Our findings indicate that IL-1β, IL-6, and RIPK3 may play potential roles in the disease process, with significantly elevated expression levels in the skin of SJS/TEN patients compared to those with lichen planus (LP) or normal controls. The gene discussed is RIPK3; the disease is lichen planus.